Utilidad de la multiespectrometría ecográfica por radiofrecuencia en el diagnóstico de la osteoporosis

Osteoporosis is a skeletal disorder characterized by decreased bone mineral density (BMD) and a disruption of bone microarchitecture, leading to an increased fracture risk. Traditionally, BMD has been measured using X-ray densitometry (DXA). However, Radiofrequency Echographic Multi Spectometry (REMS) has emerged as a promising technique for the assessment of osteoporosis. Various studies have evaluated the feasibility and precision of REMS, showing significant correlations with DXA in different anatomical sites and populations, including post-menopausal women, renal transplant patients, and those with rheumatoid arthritis, among others. REMS has also demonstrated the ability to detect bone artifacts and provide reliable measurements in their presence. While DXA remains the gold standard for diagnosing osteoporosis, REMS has proven to be an effective and promising tool in assessing BMD and fracture risk. Its capability to rule out artifacts and offer precise measurements in diverse populations highlights its potential as a complement or alternative in the evaluation of osteoporosis.